These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8854101)

  • 1. Cyclosporin-A and its metabolites in the anterior chamber after topical and systemic application as determined with high-performance liquid chromatography-electrospray mass spectrometry.
    Althaus C; Dagres E; Reinhard T; Christians U; Sundmacher R
    Ger J Ophthalmol; 1996 Jul; 5(4):189-94. PubMed ID: 8854101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison between local and systemic administration of cyclosporin A on the effective level in conjunctiva, aqueous humor and serum].
    Pfau B; Kruse FE; Rohrschneider K; Zorn M; Fiehn W; Burk RO; Völcker HE
    Ophthalmologe; 1995 Dec; 92(6):833-9. PubMed ID: 8563433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber.
    Perry HD; Donnenfeld ED; Acheampong A; Kanellopoulos AJ; Sforza PD; D'Aversa G; Wallerstein A; Stern M
    CLAO J; 1998 Jul; 24(3):159-65. PubMed ID: 9684074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of cyclosporin A in the cornea after topical or oral administration.
    Theng J; Zhou L; Tan D; La KW
    J Ocul Pharmacol Ther; 2002 Feb; 18(1):83-8. PubMed ID: 11858618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients.
    Sundelin K; Seal D; Gardner S; Ropo A; Geldsetzer K; Lokkila J; Stenevi U
    Acta Ophthalmol; 2009 Mar; 87(2):160-5. PubMed ID: 18771480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters.
    Vollenbroeker B; Koch JH; Fobker M; Suwelack B; Hohage H; Müller U
    Transplant Proc; 2005 May; 37(4):1741-4. PubMed ID: 15919451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.
    Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):465-8. PubMed ID: 10392734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops.
    Koch HR; Kulus SC; Roessler M; Ropo A; Geldsetzer K
    J Cataract Refract Surg; 2005 Jul; 31(7):1377-85. PubMed ID: 16105610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug release and biocompatibility of cyclosporine A drug delivery system implanting into the anterior chamber].
    Liu ZS; Xie LX; Shi WY; Li SW; Cai Q; Bei JZ; Wang SG
    Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):108-12. PubMed ID: 15059564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits.
    Daull P; Lallemand F; Philips B; Lambert G; Buggage R; Garrigue JS
    Cornea; 2013 Mar; 32(3):345-54. PubMed ID: 23023401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
    Benelli U; Ross JR; Nardi M; Klintworth GK
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal concentration and systemic absorption of cyclosporin-A following its topical application in the rabbit eye.
    Bellot JL; Alió JL; Ruiz Moreno JM; Artola A
    Ophthalmic Res; 1992; 24(6):351-6. PubMed ID: 1287515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of cyclosporin A in whole blood by liquid chromatography/stable isotope dilution electrospray ionization mass spectrometry.
    Magni F; Pereira S; Leoni M; Grisenti G; Galli Kienle M
    J Mass Spectrom; 2001 Jun; 36(6):670-6. PubMed ID: 11433541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
    Dutescu RM; Panfil C; Merkel OM; Schrage N
    Eur J Pharm Biopharm; 2014 Sep; 88(1):123-8. PubMed ID: 24844949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
    Reinhard T; Sundmacher R
    Klin Monbl Augenheilkd; 1997 Mar; 210(3):165-8. PubMed ID: 9206749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
    Sahin A; Bozkurt B; Irkec M
    Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.